Portfolio company
Promaxo, Inc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a point-of-care MRI platform for urologists to perform guided prostate biopsies and treatments in clinical settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ravada Health
This company develops artificial intelligence and hardware to transform MRI scanners into non-invasive pathology platforms for biopsy-saving prostate cancer diagnostics.
Exact Imaging
This company develops high-resolution micro-ultrasound systems for urologists to perform real-time imaging and guided biopsies for prostate cancer detection.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
Biobot Surgical
This company develops robotic needle guidance systems and image fusion software for hospitals and clinics to perform prostate cancer diagnosis and treatment.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
Prenuvo
The company provides whole-body MRI screening and AI-powered health reports for proactive health monitoring to individual consumers.
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
Hyperfine
This company develops portable magnetic resonance imaging systems for healthcare providers to perform brain scans at the point of care.